港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

抗疫概念

1,232.744

+37.7293.16%

涨家数：12

跌家数：5

平家数：1

市盈率：- -

高：1,234.307

开：1,195.016

低：1,182.359

收：1,195.016

数据加载中...

同源康医药-B盘中异动下午盘急速拉升5.16%

港股异动 | 创新药概念多数走高行业迎政策红利密集释放期 BD有望加速创新药重估

康希诺AH股齐拉升：A股涨超16%，H股涨近14%，均创阶段新高

广药白云山斥14亿设广药基金二期，加速布局生物医药健康

南方都市报

ETF午评 | 创新药板块强势上涨，创新药ETF天弘、药ETF涨2%

中国生物制药上涨5.02%，报7.11元/股

港股异动 | 中生制药(01177)再涨超6% 机构称BD交易有望成为公司的经常性收入和利润来源

石药集团盘中异动股价大涨3.01%报8.890港元

大行评级｜大摩：中国中药日前发盈警，预期股价将于未来30天内下跌

创新药概念部分上扬恒瑞医药(01276)涨近9% 汇丰预计板块强劲势头将维持

中国生物制药盘中异动早盘快速上涨3.55%

港股异动 | 中国中药(00570)低开逾4% 预计上半年纯利净额同比下降165%至175%

比亚迪申请检测元件等相关专利，提高检测元件的多功能性

歌礼制药-B(01672)：小分子GLP-1R激动剂ASC30每月一次皮下储库型制剂的美国12周IIa期研究完成首批肥胖或超重受试者给药

全球电动车市：比亚迪占“半壁江山”，吉利星愿挺进前三

盖世汽车社区

《盈警》中国中药(00570.HK)计提商誉减值预计中绩下跌

阿斯达克财经

多股涨幅翻倍！医药板块频获加仓，什么情况？

广药白云山拟出资14.985亿元参与设立广药基金二期

集采大幕拉开！达格列净片，迎来颠覆时刻？

长城基金谭小兵：医药投资中的长期主义

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK1515/news?page=4"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":1232.7441,"timestamp":1753776507445,"preClose":1195.0156,"halted":0,"volume":976115698,"delay":0,"changeRate":0.031572,"floatShares":0,"shares":0,"eps":0,"marketStatus":"已收盘","change":37.728516,"latestTime":"07-29 16:00:00","open":1195.0156,"high":1234.3068,"low":1182.3589,"amount":8844656080.82,"amplitude":0.04347,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753839000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1753752600000,1753761600000],[1753765200000,1753776000000]],"pbRate":2.002119,"peRate":26.755366,"turnoverRate":0.013023,"increases":13,"decrements":5,"flats":0,"marketCap":840345601920,"floatMarketCap":700775683328},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":1234.3068,"amplitude":0.04347,"preClose":1195.0156,"low":1182.3589,"pbRate":"2.002119","latestPrice":1232.7441,"volume":976115698,"delay":0,"open":1195.0156,"prevYearClose":787.97723,"prevWeekClose":1162.91,"prevMonthClose":1028.719,"prevQuarterClose":1028.719,"fiveDayClose":1155.719,"twentyDayClose":1028.719,"sixtyDayClose":921.416,"secType":"PLATE","market":"HK","turnoverRate":0.013023,"peRate":26.755366,"marketCap":840345601920,"floatMarketCap":700775683328,"timestamp":1753776507445,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":12,"down":5,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2554251347","title":"同源康医药-B盘中异动 下午盘急速拉升5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554251347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554251347?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 14:56","pubTimestamp":1753685802,"startTime":"0","endTime":"0","summary":"2025年07月28日下午盘14时56分，同源康医药-B股票出现波动，股价急速上涨5.16%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。同源康医药-B股票所在的生物技术行业中，整体涨幅为2.34%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281456429722a7aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507281456429722a7aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","09939","02410","BK1574"],"gpt_icon":0},{"id":"2554672566","title":"港股异动 | 创新药概念多数走高 行业迎政策红利密集释放期 BD有望加速创新药重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2554672566","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554672566?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 14:52","pubTimestamp":1753685525,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ08YT58.USD","159992","LU1997245094.SGD","LU2488822045.USD","LU2495084118.USD","01530","BK0012","BK0028","BK0188","LU0405327148.USD","03692","BK1191","BK0183","BK1515","BK1521","01276","600276","IE00BZ08YS42.EUR","LU0405327494.USD","01177","BK1589","LU1064131003.USD","BK1593","BK1161","LU1064130708.USD","01801","BK0060","LU2148510915.USD","BK0239","LU1997244956.HKD","BK1574","LU2328871848.SGD","LU1969619763.USD","BK1583","06978","02096","LU1655091616.SGD","IE00BZ08YR35.GBP","LU1328615791.USD","LU1997245177.USD","BK0196"],"gpt_icon":0},{"id":"2554234247","title":"康希诺AH股齐拉升：A股涨超16%，H股涨近14%，均创阶段新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2554234247","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554234247?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 14:14","pubTimestamp":1753683256,"startTime":"0","endTime":"0","summary":"疫苗股继续活跃，其中，康希诺AH股午后拉升，A股一度涨超16%报82.48元，股价创2023年12月以来新高；H股拉升一度涨近14%报48.55港元，股价创2023年3月以来新高。消息面上，基孔肯雅热在广东佛山市的爆发继续成为市场关注的焦点。据广东省疾控局消息，2025年7月20日0时至7月26日24时，广东省新增报告2940例基孔肯雅热本地病例，未报告重症和死亡病例。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072814142697229697&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072814142697229697&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","BK1191","BK1574","06185"],"gpt_icon":0},{"id":"2554280397","title":"广药白云山斥14亿设广药基金二期，加速布局生物医药健康","url":"https://stock-news.laohu8.com/highlight/detail?id=2554280397","media":"南方都市报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554280397?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 13:21","pubTimestamp":1753680095,"startTime":"0","endTime":"0","summary":"7月25日，广药集团旗下上市公司白云山（600332.SH，00874.HK）发布公告称，拟作为有限合伙人以自有资金出资14.985亿元参与设立广州广药基金二期股权投资合伙企业（简称“广药基金二期”）。根据公告，广药基金二期的设立结构为：广药白云山认缴14.985亿元，占99.9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507283468986054.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1197","BK1521","BK1515","BK1606","BK1191","00874"],"gpt_icon":0},{"id":"2554174741","title":"ETF午评 | 创新药板块强势上涨，创新药ETF天弘、药ETF涨2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554174741","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554174741?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 11:40","pubTimestamp":1753674048,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["562050","159945","PCB","BK0196","BK1161","BK4211","BK0028","515120","159992","09939","399001","159940","01336","516020","FDN","159392","159870","159938","159227","BK0183","399006","161024","BK1515","BK1184","BK4550","399300","BK1574","BK0188","BK4585","161032","BK0207","06978","BK1550","BK4588","561260","601336","513750","SG9999006597.SGD","BK0012","159930","000680.SH","515220","BK1584","159982"],"gpt_icon":0},{"id":"2554261747","title":"中国生物制药上涨5.02%，报7.11元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2554261747","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554261747?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 11:33","pubTimestamp":1753673630,"startTime":"0","endTime":"0","summary":"7月28日，中国生物制药盘中上涨5.02%，截至11:07，报7.11元/股，成交7.77亿元。中国生物制药有限公司是一家创新研究和研发驱动型的医药集团，其主要业务包括医药研发、智能化生产以及销售，主要产品包括多种生物药和化学药，特别在肿瘤、肝病、呼吸系统、外科/镇痛四大治疗领域具有优势。截至2024年年报，中国生物制药营业总收入288.66亿元、净利润35.0亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728113659a6c51c5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728113659a6c51c5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","IE00BZ08YR35.GBP","BK1521","IE00BZ08YS42.EUR","01177","BK1191","BK1589","IE00BZ08YT58.USD"],"gpt_icon":0},{"id":"2554747987","title":"港股异动 | 中生制药(01177)再涨超6% 机构称BD交易有望成为公司的经常性收入和利润来源","url":"https://stock-news.laohu8.com/highlight/detail?id=2554747987","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554747987?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 11:26","pubTimestamp":1753673211,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中生制药再涨超6%，年内累计涨幅已近130%。据悉，中生制药7月15日宣布，以超5亿美元净额收购礼新医药近95.09%股份。中银国际发表研报称，考虑到礼新医药多项资产在全球市场拥有一定潜力，预期中生制药有1至2宗授权交易变得更具可见性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322458.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1574","IE00BZ08YR35.GBP","01477","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1589","BK1521","01177","BK1515"],"gpt_icon":0},{"id":"2554747685","title":"石药集团盘中异动 股价大涨3.01%报8.890港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554747685","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554747685?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 11:11","pubTimestamp":1753672279,"startTime":"0","endTime":"0","summary":"2025年07月28日早盘11时11分，石药集团股票出现波动，股价急速上涨3.01%。截至发稿，该股报8.890港元/股，成交量6797.92万股，换手率0.59%，振幅4.29%。资金方面，该股资金流入3.02058亿港元，流出2.27972亿港元。石药集团股票所在的药品行业中，整体涨幅为2.04%。消息层面，截至11时11分，《不再锚定最低价 国家药品集采明确反内卷》资讯为影响石药集团的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072811112094be7217&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072811112094be7217&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B031HY20.USD","LU1008478684.HKD","LU1226287529.USD","LU1993786604.SGD","IE0008368742.USD","IE00B543WZ88.USD","IE00B5MMRT66.SGD","LU1226288170.HKD","LU1152091168.USD","LU0326950275.SGD","01093","BK1515","LU1226288253.USD","IE0008369823.USD","BK1191","LU0315179316.USD","SG9999004220.SGD","LU1960683339.HKD","LU1951186391.HKD","LU0140636845.USD","LU0072913022.USD","LU1226287875.USD","LU1152091754.HKD","BK1521","LU1807302812.USD","IE00BZ08YT58.USD","LU0067412154.USD","LU0501845795.SGD","LU0880133367.SGD","IE00BZ08YR35.GBP","LU1226287792.SGD","IE00BZ08YS42.EUR"],"gpt_icon":0},{"id":"2554174231","title":"大行评级｜大摩：中国中药日前发盈警，预期股价将于未来30天内下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2554174231","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554174231?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 10:34","pubTimestamp":1753670076,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1191","BK1606","00570","BK1515"],"gpt_icon":0},{"id":"2554744921","title":"创新药概念部分上扬 恒瑞医药(01276)涨近9% 汇丰预计板块强劲势头将维持","url":"https://stock-news.laohu8.com/highlight/detail?id=2554744921","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554744921?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 09:49","pubTimestamp":1753667364,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念部分上扬，恒瑞医药(01276)涨8.96%，中国生物制药(01177)涨4.28%，绿叶制药(02186)涨4.02%，巨子生物(02367)涨4%，先声药业(02096)涨2.43%，再鼎医药(09688)涨1.78%。汇丰研究报告指，年初至今内地医药股跑赢大市，该行自年初起持续看好创新药领域，并预计强劲势头将维持。基于丰富的研发管线和临床进展，该行预期2026至29年将有多款新药推出，且今年下半年公布的临床数据有望进一步推动对外授权合作(BD)。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962962","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064131003.USD","BK1521","BK4588","LU1328615791.USD","LU1997245177.USD","BK0188","600276","02096","BK1191","IE00BZ08YS42.EUR","SG9999004311.SGD","159992","02367","LU0310800965.SGD","LU2236285917.USD","02186","BK1515","LU0052756011.USD","LU1969619763.USD","BK0183","BK1161","LU2495084118.USD","BK1589","BK4521","LU0405327494.USD","01276","LU1064130708.USD","BK0012","LU1267930227.SGD","BK1574","BK4207","01177","LU0128525689.USD","LU1997244956.HKD","BK0060","LU1997245094.SGD","LU1655091616.SGD","09688","LU2148510915.USD","BK1588","06978","BK1207","HSBC","BK1606","IE00BZ08YT58.USD","BK0028","LU2488822045.USD","BK0239","BK1583","BK0196"],"gpt_icon":0},{"id":"2554744070","title":"中国生物制药盘中异动 早盘快速上涨3.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554744070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554744070?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 09:30","pubTimestamp":1753666219,"startTime":"0","endTime":"0","summary":"2025年07月28日早盘09时30分，中国生物制药股票出现异动，股价急速拉升3.55%。截至发稿，该股报7.010港元/股，成交量1117.41万股，换手率0.06%，振幅2.07%。中国生物制药股票所在的药品行业中，整体涨幅为2.42%。其相关个股中，恒瑞医药、培力农本方、中国生物制药涨幅较大，振幅较大的相关个股有恒瑞医药、绿叶制药、三生制药，振幅分别为4.41%、2.76%、2.28%。中国生物制药公司简介：本集团业务覆盖医药各种研发平台、智能化生产和强大销售体系全产业链。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728093019a6c4d8a8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728093019a6c4d8a8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ08YS42.EUR","BK1589","BK1191","IE00BZ08YR35.GBP","BK1515","BK1521","IE00BZ08YT58.USD","01177"],"gpt_icon":0},{"id":"2554741197","title":"港股异动 | 中国中药(00570)低开逾4% 预计上半年纯利净额同比下降165%至175%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554741197","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554741197?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 09:23","pubTimestamp":1753665792,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国中药(00570)低开逾4%，截至发稿，跌4.31%，报2.22港元，成交额1254.74万港元。消息面上，中国中药发布盈警，预计上半年溢利净额将较2024年同期下降165%-175%。主要因中药配方颗粒业务受集采业务占比增加、市场竞争加剧等影响，收入规模及盈利能力下降；及中药配方颗粒业务经营财报不达预期，就业务资产组进一步计提商誉减值。董事会强调，上述计提商誉减值属非现金性质，乃为使集团财政状况未来可取得改善而采取的必要措施。上述减值对集团现金流量或业务及生产营运并无任何影响。若扣除商誉减值的影响，预计集团本期仍有盈利，但较2024年同期同比下降50%-60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"港股异动 | 中国中药(00570)低开逾4% 预计上半年纯利净额同比下降165%至175%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1515","BK1606","00570","BK1191"],"gpt_icon":0},{"id":"2554741780","title":"比亚迪申请检测元件等相关专利，提高检测元件的多功能性","url":"https://stock-news.laohu8.com/highlight/detail?id=2554741780","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554741780?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 09:20","pubTimestamp":1753665619,"startTime":"0","endTime":"0","summary":"金融界2025年7月28日消息，国家知识产权局信息显示，比亚迪股份有限公司申请一项名为“检测元件、电池包、电池包的检测方法以及用电设备”的专利，公开号CN120369159A，申请日期为2025年04月。通过天眼查大数据分析，比亚迪股份有限公司共对外投资了104家企业，参与招投标项目987次，财产线索方面有商标信息1820条，专利信息5000条，此外企业还拥有行政许可151个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809333794be4723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072809333794be4723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0540923850.HKD","LU1242518931.SGD","LU1251922891.USD","LU0588545904.SGD","HYDD.SI","BYDDY","LU1720050803.USD","BK1515","LU2357125470.USD","LU0828238088.HKD","LU0516423174.USD","LU0588546209.SGD","LU1861219969.SGD","LU2506951792.HKD","LU1813983027.USD","LU0084288322.USD","81211","LU0165289439.USD","LU0307460666.USD","LU0979878070.USD","LU1242518857.USD","LU0417516738.SGD","LU0865486749.SGD","LU0214875030.USD","LU0531971595.HKD","LU2249611893.SGD","LU1188198961.HKD","LU2097828714.EUR","LU2476274720.SGD","BK1589","BK1509","BK1610","LU2476274308.USD","LU0348827113.USD","LU2097828474.EUR","LU0359201885.HKD","LU0269904917.USD","00285","01211","BK1540","LU0823414551.USD","LU0543330566.HKD","LU0561508036.HKD","SG9999015945.SGD","002594","BK1119","LU2153592121.USD","SG9999015986.USD","LU0244354667.USD","LU0449509016.USD"],"gpt_icon":1},{"id":"2554698749","title":"歌礼制药-B(01672)：小分子GLP-1R激动剂ASC30每月一次皮下储库型制剂的美国12周IIa期研究完成首批肥胖或超重受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2554698749","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554698749?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 08:17","pubTimestamp":1753661877,"startTime":"0","endTime":"0","summary":"智通财经APP讯，歌礼制药-B 发布公告，小分子GLP-1受体激动剂 ASC30每月一次皮下储库型制剂治疗肥胖症的美国12周IIa期研究已完成首批受试者给药，受试者为肥胖人群或伴有至少一种体重相关合并症的超重人群。预计将于2026年第一季度获得顶线数据。ASC30是一款正在临床研究中的小分子GLP-1R偏向激动剂，具有独特和差异化性质，使得同一小分子同时适用于口服片剂和皮下注射给药成为可能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1322370.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1191","BK1515","BK4590","BK1574","BK4144","GLP","01672","01477"],"gpt_icon":0},{"id":"2554469477","title":"全球电动车市：比亚迪占“半壁江山”，吉利星愿挺进前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2554469477","media":"盖世汽车社区","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554469477?lang=zh_cn&edition=fundamental","pubTime":"2025-07-28 07:03","pubTimestamp":1753657412,"startTime":"0","endTime":"0","summary":"此外，比亚迪的海狮05注册量攀升至1.5万辆，首次进入全球前20榜单，这也使得比亚迪在5月全球电动汽车注册量TOP20榜单中独占10款车型，占据“半壁江山”。比亚迪海鸥和吉利星愿均展现出强劲增长势头，对特斯拉Model 3构成潜在威胁。吉利持续攀升，特斯拉市场份额下跌一半从品牌层面来看，5月份，全球销量前三为比亚迪、特斯拉和吉利。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728070848a6c4a6a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250728070848a6c4a6a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0348766576.USD","LU0164872284.USD","002594","LU0823414551.USD","HYDD.SI","LU0348827113.USD","LU0828238088.HKD","LU1242518931.SGD","LU0315178854.USD","01211","SG9999015952.SGD","BK1582","LU0417516902.SGD","LU1868837565.USD","LU0823038988.USD","LU0327786744.USD","LU0348805143.USD","LU0516422440.USD","LU0084288322.USD","LU2476274720.SGD","LU0543330566.HKD","SG9999014674.SGD","BK1119","LU0359201612.USD","SG9999006514.SGD","BK1589","LU0143863198.USD","LU1861214812.USD","LU1251922891.USD","LU0348767384.USD","LU0164865239.USD","LU1880383366.USD","LU2360107325.USD","LU0269904917.USD","LU0326950275.SGD","BK1515","LU0594300179.USD","LU1794554557.SGD","BYDDY","LU1770034418.SGD","LU0314109678.HKD","LU1880383440.USD","LU0823426480.USD","BK1504","81211","LU0572944931.SGD","LU0593848301.USD","00285","LU2097828714.EUR","BK1580"],"gpt_icon":1},{"id":"2554710949","title":"《盈警》中国中药(00570.HK)计提商誉减值  预计中绩下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2554710949","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554710949?lang=zh_cn&edition=fundamental","pubTime":"2025-07-27 16:19","pubTimestamp":1753604340,"startTime":"0","endTime":"0","summary":"中国中药发盈警，预计6月止六个月溢利净额将较2024年同期下降165%-175%。主要因中药配方颗粒业务受集采业务占比增加、市场竞争加剧等影响，收入规模及盈利能力下降；及中药配方颗粒业务经营业绩不达预期，就业务资产组进一步计提商誉减值。过往派息公布日期派息事项派息内容2025/03/25末期业绩特别股息：港元 0.0830 2025/03/25末期业绩股息：港元 0.0035 2024/08/28中期业绩无派息2024/03/21末期业绩无派息撇除商誉减值，预计期内仍有盈利，惟较2024年同期下降50%-60%。沽空资料截至 2025-07-25 16:25。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240130110317502_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240130110317502_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1456190/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00570","BK1191","BK1606","BK1515"],"gpt_icon":0},{"id":"2554192147","title":"多股涨幅翻倍！医药板块频获加仓，什么情况？","url":"https://stock-news.laohu8.com/highlight/detail?id=2554192147","media":"e公司","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554192147?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 22:30","pubTimestamp":1753540200,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　部分医疗股今年以来涨幅翻倍。数据显示，医药生物板块本周再获资金流入。　　本周，A股继续稳步走高，上证指数一度冲上3600点，创年内新高；深证成指则突破11000点，也创年内新高；创业板指、沪深300、上证50等也纷纷创出阶段性新高。周成交额快速放大至9.24万亿元，创5个月新高。投资者据此操作，风险自担。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-07-26/doc-infhvmwi0410068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","159938","BK1515","BK1574","09939"],"gpt_icon":0},{"id":"2554719632","title":"广药白云山拟出资14.985亿元参与设立广药基金二期","url":"https://stock-news.laohu8.com/highlight/detail?id=2554719632","media":"广州日报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554719632?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 19:47","pubTimestamp":1753530476,"startTime":"0","endTime":"0","summary":"7月25日，广药集团旗下上市公司广州白云山医药集团股份有限公司（以下简称“广药白云山”，股票代码：600332.SH，00874.HK）发布公告称，公司拟作为有限合伙人以自有资金出资14.985亿元参与设立广州广药基金二期股权投资合伙企业（以下简称“广药基金二期”），占广药基金二期认缴出资总额的99.90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507263468307715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1515","BK1521","00874","BK1197","BK1606"],"gpt_icon":0},{"id":"2554154477","title":"集采大幕拉开！达格列净片，迎来颠覆时刻？","url":"https://stock-news.laohu8.com/highlight/detail?id=2554154477","media":"浩海投研","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554154477?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 15:36","pubTimestamp":1753515360,"startTime":"0","endTime":"0","summary":"本次集采最终纳入了55个品种，适应症覆盖抗菌药物、心血管等多个治疗领域。本次集采废除了明确低价保护线，以弹性表述防止无序竞争。围绕达格列净片的专利之争非常有趣。对于达格列净片这个品种而言，国内药企有望通过参与集采扩大市场份额，为患者提供更具性价比的药品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726154041a464713b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726154041a464713b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1226288253.USD","IE00BZ08YS42.EUR","LU1152091168.USD","IE00BZ08YT58.USD","BK1589","LU1993786604.SGD","BK1583","LU0880133367.SGD","LU1960683339.HKD","IE0008369823.USD","IE00B031HY20.USD","SG9999004220.SGD","LU0140636845.USD","03692","LU0326950275.SGD","LU0315179316.USD","600789","LU0072913022.USD","LU1152091754.HKD","IE0008368742.USD","LU1951186391.HKD","BK1521","AZN","601089","LU1008478684.HKD","BK1515","LU1226287529.USD","LU1226287792.SGD","LU0067412154.USD","LU1226288170.HKD","01093","IE00BZ08YR35.GBP","LU0501845795.SGD","LU1226287875.USD","LU1807302812.USD","BK1191","IE00B543WZ88.USD","IE00B5MMRT66.SGD"],"gpt_icon":0},{"id":"2554923718","title":"长城基金谭小兵：医药投资中的长期主义","url":"https://stock-news.laohu8.com/highlight/detail?id=2554923718","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554923718?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 10:06","pubTimestamp":1753495560,"startTime":"0","endTime":"0","summary":"创新药加速出海、企业盈利改善，为医药投资带来了新的机会。（指数过往业绩不代表其未来表现，不等于产品实际收益，市场有风险，投资须谨慎。　　在这股创新药投资热潮中，长城基金医药投资团队管理的主动基金表现突出。　　谭小兵在2016年正式管理公募产品之前，除了研究医药行业，还有过多年建筑、建材、电力等跟宏观经济强相关行业的研究经历。　　在长城医疗保健A这只产品上，我们能一睹谭小兵这种强调“大局观”的投资风格。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/jjh/2025-07-26/doc-infhueca7471748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","BK1515","BK1574","09939","159938"],"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":4,"totalSize":409,"code":"91000000","status":"200"}]}}